FONET BİLGİ TEKNOLOJİLERİ A.Ş.

Interim / Quarterly Report • Aug 18, 2025

FONET BİLGİ TEKNOLOJİLERİ ANONİM ŞİRKETİ LIMITED REVIEW REPORT ON THE COMPLIANCE OF THE INTERIM ACTIVITY REPORT

(Convenience translation originally issued in Turkish)

To the Board of Directors of Fonet Bilgi Teknolojileri A.Ş.

Introduction

We have reviewed the accompanying interim consolidated statement of financial position of Fonet Bilgi Teknolojileri A.Ş.(the Company) and its subsidiaries (the Group) as of 30 June 2025 and the interim consolidated statement of profit or loss and other comprehensive income, consolidated statement of changes in equity and the consolidated statement of cash flows for the six-month period then ended, and a summary of significant accounting policies and other explanatory notes. The Group management is responsible for the preparation and fair presentation of these interim consolidated financial statements in accordance with Turkish Financial Reporting Standards. Our responsibility is to express a conclusion on these interim consolidated financial statements based on our review.

Scope of Review

We conducted our review in accordance with the Standard on Review Engagements (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity". A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review of interim financial information is substantially less in scope than an audit conducted in accordance with Independent Auditing Standards and the objective of which is to express an opinion on the financial statements. Consequently, a review of the consolidated interim financial information does not provide assurance that the audit firm will be aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the accompanying interim consolidated financial statements do not present fairly, in all material respects, the consolidated financial position of the Group as at 30 June 2025, and its consolidated financial performance and its consolidated cash flows for the six-month period then ended in accordance with Turkish Financial Reporting Standards.

EREN Bağımsız Denetim A.Ş. Member Firm of Grant Thornton International

Nazım Hikmet Sorumlu Ortak Baş Denetçi

İstanbul, 18.08.2025

FONET INFORMATION TECHNOLOGIES INC.

INTERIM PERIOD ACTIVITY REPORT OF THE BOARD OF DIRECTORS

01 January 2025 – 30 June 2025

"Strong Accumulation Innovative Technology"

I.	ABOUT US	3
II.	CAPITAL STRUCTURE	4
III.	INFORMATION ON PRIVILEGED SHARES	5
IV.	COMPANY MANAGEMENT AND EMPLOYEE INFORMATION	6
V.	CORPORATE ACTIVITIES	8
VI.	FINANCIAL CONDITION OF THE COMPANY	8
VII.	STOCK INFORMATION10
VIII.	SOURCES OF FINANCE11
IX.	AMENDMENTS IN THE COMPANY'S ARTICLES OF ASSOCIATION11
X.	BENEFITING FROM THE GOVERNMENT PROMOTIONS17
XI.	RESEARCH AND DEVELOPMENT ACTIVITIES17
XII.	SUBSIDIARIES AND BRANCHES OF THE COMPANY17
XIII.	OTHER ISSUES18

I. ABOUT US

Fonet Information Technology A.Ş (The Company) is subject to the laws of the Republic of Türkiye, Capital Market Law, and the provisions of the Turkish Commercial Code relating to the establishment of joint stock companies. Therefore, it operates in accordance with the provisions contained in the Turkish Commercial Code and Capital Market Law especially the provisions contained in the articles of association of the company, and on the condition that it stays within the scope of business.

Accordingly, the main business issue of The Company is the "Information Technology Sector" and its activity is defined in detail in Article 3 titled purpose and subject of the articles of association.

Trade Name	Fonet Bilgi Teknolojileri A.Ş.
Establishment Date	10.01.2001
Area of Activity	Software/Informatics
Paid – in Capital	144.000.000 TL
Upper Limit of Registered Capital	2.500.000.000 TL
Address	The Paragon Tower 1445th Street, No: 2B/1 Kızılırmak District Çankaya /ANKARA
Phone	+90 312 438 59 19
Fax	+90 312 440 36 52
Trade Registry No	350735
E-Mail Address	fonet@fonetbt.com
Website	www.fonetbt.com

FONET; has been founded in 1997 to serve the IT healthcare sector. It is an IT company that turned into a limited liability Corporation in 2001 and then, turned into a joint-stock company in 2011. It gives services turnkey projects in the Healthcare IT field which are related to Information Management Systems, System Integration, and Consultancy services. Despite healthcare information technology being the main activity subject of Fonet, it is also involved in different information technology projects with field expertise.

Within the scope of the transformation in the health sector in our country in the late 90s and early 2000s, we focused on the health sector in line with the use of information technologies in the health sector and having Health Institutions serving at international standards and started to produce solutions in this context. It follows improving technology and regarding regulations closely and it keeps itself updated. Fonet's aim is to reach all international standards in all hospitals which has been given service by Fonet in the healthcare informatics system field.

Mission

Developing advanced technology and also develop. In this way, we contribute to Turkey's economy and we intended to strengthen Turkey's position in the global marketplace.

Vision

To be a leader company in its sector that provides development and change with advanced technology in the information sector continuously increases value created for its customers, gives a quality service with knowledge of technology, professional team, entrepreneur, and customer-oriented approach.

II. CAPITAL STRUCTURE

The company, which has adopted the registered capital system, has set its registered authorized capital (upper limit) to 2.500.000.000 Turkish Liras until the year 2028 along with the permission of the Capital Markets Board.

The company's issued capital is 144.000.000,00 Turkish Liras which has been paid in full within the upper limit of registered capital.

The company started to be traded in Istanbul stock on May 04, 2017. Details of the shares thatform the capital ofthe company, which has started trading in the BIST MAIN/ BIST TECHNOLOGY / BIST INFORMATICS/ BIST ALL SHARES / BIST ALL SHARES-100 / BIST ANKARA / BIST PARTICIPATION ALL/ BIST PARTICIPATION 100 / BIST 500 markets, are as shown in the table below;

SHAREHOLDER	SHARE IN CAPITAL (TL)	RATIO IN CAPITAL (%)	VOTING RIGHT RATIO (%)
ABDÜLKERİM GAZEN	55.217.999,16	38,35	65,32
OTHER	88.782.000,84	61,65	34,68
TOTAL	144.000.000,00	100	100

III. INFORMATION ON PRIVILEGED SHARES

Privileged Share Amount (Number): 7.999.999,992 A Group Equity

Privileged Share Amount (TL): 7.999.999,992 TL

Explanations on Voting Rights of Privileged Shares

Each share in the General Assembly has 15 Voting Rights. If the company's Board of Directors consists of five members, two board members; consists of six or seven members, three board members; consists of eight or nine members, four board members of the Board of Directors (A) are elected by the General Assembly among the candidates to be determined by the shareholders.

If the shareholders of the group (A) does not nominate to the Board of directors, the election shall be held by the General Assembly within the framework of the Capital Markets legislation and the provisions of the Turkish commercial code.

Articles of Association Article 6:

Group (A) shares have the privilege to determine the members of the Board of Directors and also have the right to vote in the General Assembly.

Group (B) shares have no privileges.

Articles of Association Article 10:

At Ordinary and Extraordinary General Assembly Meetings (A) group shareholders have 15 voting rights for each share, (B) group shareholders have 1 voting rights for each one share.

IV. COMPANY MANAGEMENTANDEMPLOYEEINFORMATION

The management and representation of the Company belong to the Board of Directors. The business and administration of the Company is carried out by 6 Members of the Board of Directors elected by the General Assembly in accordance with the provisions of the Turkish Commercial Code. Members of the Board of Directors can be elected for a maximum of 3 years. The Board of Director Members whose term of office expires can be elected again.

The chairman of the Board of Directors is elected by the members of the Board of Directors that the (A) group of shareholders offer. The Members of The Board of Directors can also be The Members of The Board of Directors of the other companies.

The Members of The Board of Directors do not have activities within the scope of Prohibition of competing with the company through transactions on behalf of the company, itself, or others.

NAME & SURNAME	ROLE	DUTY TERM
Abdülkerim GAZEN	Chair	10.04.2025 - 10.04.2028
Yasemin ŞAH	Vice Chair	10.04.2025 - 10.04.2028
Dr. Emre SEZGİN	Member	10.04.2025 - 10.04.2028
Daniel Anders Henrik WERNER	Member	10.04.2025 - 10.04.2028
Nisabeyim GAZEN	Member	10.04.2025 - 10.04.2028
Prof. Dr. Muhammet Ali AKCAYOL	Independent Member	10.05.2023 – 10.05.2026
Prof. Dr. Sinan Altan KOCAMAN	Independent Member	10.04.2025 – 10.04.2028

BOARD OF DIRECTORS

COMMITTIEES

In order for the Board of Directors to perform its duties and responsibilities in a sound manner, Pursuant to Article 4.5 of the corporate governance communiqué no: II-17.1 of the Capital Markets Board, the Board of Directors has decided to create the "Audit Committee", "Early Detection of Risk Committee" and "Corporate Governance Committee" and determine job definitions; The board of Directors has decided not to establish a different "Nomination Committee" and "Compensation Committee", in place of this regarding committee's duties have been undertaken by the "Corporate Governance Committee".

Audit Committee

The audit committee supervises the company's accounting system, public disclosure of financial information, independent audit, and the functioning and effectiveness of the company's internal control and internal audit system.

NAME & SURNAME	ROLE	TITLE
Prof. Dr. Muhammet Ali AKCAYOL	Chairman of the Audit Committee Independent Board Member
Prof. Dr. Sinan Altan KOCAMAN	Member of the Audit Committee	Independent Board Member

Early Detection of Risk Committee

Early Detection of Risk Committee; it is responsible for early identification of risks that may endanger the existence, development and continuation of the company, taking necessary measures regarding the identified risks, and carrying out activities to manage the risk and it reviews risk management systems. The committee evaluates the situation in its report to the board of directors every two months, points out the dangers, if any, and shows the remedies.

NAME & SURNAME	ROLE	TITLE
Prof. Dr. Sinan Altan KOCAMAN	Early Detection of Risk Committee Chairman	Independent Board Member
Dr. Emre SEZGİN	Early Detection of Risk Committee Member	Board Member

Corporate Governance Committee

The corporate governance committee determines whether corporate governance principles are applied in the company, if not, its rationale and conflicts of interest that arise from not fully complying with these principles, and advises the board of directors to improve corporate governance practices and it supervises the work of the investor relations department.

NAME & SURNAME	ROLE	TITLE
	Prof. Dr. Muhammet Ali AKCAYOL Corporate Governance Committee Chairman	Independent Board Member
Dr. Emre SEZGİN	Corporate Governance Committee Member	Board Member
Meltem KAVAK	Corporate Governance Committee Member	Investor Relations Manager

As of 30th June, 2025, the number of personnel is 499 and the distribution is as follows:

EMPLOYEE DISTRIBUTION	NUMBER
Administrative Staff	15
R&D Staff	122
Company Headquarters Total		137
Techinical Staff *	362
Total		499

* Within the scope of the contracts, they are the personnel working in the hospitals related to the fixed-term employment contract.

V. CORPORATE ACTIVITIES

In the relevant accounting period, there is no legal action taken for the benefit of the company, its parent company and its subsidiary, or its subsidiary with the guidance of the parent company, or any measures taken or avoided for the benefit of the parent partner or its subsidiary.

In the relevant accounting period, all of the commercial activities performed between both its controlling shareholder and its subsidiary were realized in accordance with market conditions. There are no administrative or judicial sanctions imposed on the company and its managers due to practices contrary to the provisions of the law. Detailed information on other activities that are conducted is summarized under "XIII other issues".

VI. FINANCIAL CONDITION OF THE COMPANY

Budget objective has been attained.

• The net profit of our company for the period of 1st January 2025 30th June 2025 is 34.182.861 Turkish Lira; the size of assets is 1.737.789.524 Turkish Lira and the total equity is 1.344.401.466 Turkish Lira.
• The financial statements of the company for the period of 1st January 2025 30th June 2025 are presented below:

STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME

	30 June 2025	30 June 2024
CONTINUING OPERATIONS
Revenue	289.584.802	319.498.896
Cost of Sales (-)	-193.186.078	-208.030.202
GrossProfit(Loss)FromCommercial Operations	96.398.724	111.468.694
General Administrative Expenses (-)	-39.219.190	-33.211.559
Marketing Expenses (-)	-4.111.710	-3.179.060
Research and Development Expense (-)	-1.926.351	-2.181.329
Other Income from Operating Activities	28.744.025	59.587.265
Other Expenses from Operating Activities (-)	-4.051.777	-15.284.918
PROFIT (LOSS) FROM OPER. ACTIVITY (-)	75.833.721	117.199.093
Investment Activity Income	-	4.882.363
Investment Activity Costs	-	-
PROFIT (LOSS) BEF. FIN. INCOME (EXPENSE)	75.833.721	122.081.456
Finance Incomes	3.063.391	1.165.987
Finance Costs (-)	-7.904.041	-4.123.191
Monetary Loss / Gain due to Inflation	-28.903.875	-3.518.679
PROFIT (LOSS) FROM CONTINUING OPERATIONS, BEFORE TAX	42.089.196	115.605.573
Tax (Expense) Income, Continuing Ops. (-)	-7.906.335	-20.501.164
Current Income Tax Expense	-	-
Deferred Tax (Expense) Income (-)	-7.906.335	-20.501.164
PROFIT (LOSS) FROM CONTINUING OPS.	34.182.861	95.104.409
PROFIT (LOSS)	34.182.861	95.104.409

STATEMENT OF FINANCIAL POSITION (BALANCE SHEET)

ASSETS	30 June 2025	31December 2024
Current Assets	146.098.441	97.554.756
Nun-Current Assets	1.591.691.083	1.310.191.174
1.737.789.524 TOTAL ASSETS		1.407.745.930
LIABILITIES	30 June 2025	31 December 2024
Current Liabilities	92.315.309	78.907.516
Non-Current Liabilities	301.072.749	18.430.520
Equity	1.344.401.466	1.310.407.894

RATIOS

LIQUIDITY RATIOS	30 June 2025	31 December 2024
Current Ratio	1,58	1,24
Liquid Ratio	1,12	1,24
Cash Ratio	0,23	0,56
FINANCIAL STRUCTURE RATIOS	30 June 2025	31 December 2024
Leverage Ratio	0,23	0,07
Financing Ratio	3,42	13,46
Debt Equity Ratio	0,29	0,07
PROFITABILITY RATIOS	30 June 2025	31 December 2024
Asset Profitability	0,02	0,12
Equity Profitability	0,03	0,13

VII. STOCK INFORMATION

Public Offering Date: 27-28 April 2017

Total Equity: 144.000.000,00 TL (Nominal worth of each share is 1 TL).

Free Float Rate: %61,65

StockMarketCode:FONET

Code:TREFONT00028

Involving Group in Stock Market: BIST MAIN

Involving Index: BIST ALL SHARES-100 / BIST ALL SHARES / BIST INFORMATICS / BIST TECHNOLOGY / BIST ANKARA / BIST MAIN /BIST PARTICIPATION ALL / BIST PARTICIPATION 100 / BIST 500

The public offering date of the company's shares is 27-28 April 2017. The shares are started to be traded on Borsa Istanbul as of May 04, 2017. The market price of our company's shares is 14,70 TRY as of June 30, 2025.

VIII. SOURCES OF FINANCE

The finance sources of the company are its own equity and bank loans.

IX. CHANGES IN THE COMPANY'S ARTICLES OF ASSOCIATION

The Company's Articles of Association did not change during the period.

X. BENEFITINGFROM THEGOVERNMENTPROMOTIONS

Being R&D Center

As a result of the evaluation made by the Ministry of Science, Industry and Technology Evaluation and Audit Commission, it was deemed appropriate to certify as R&DCenter. Thus, the company has been entitled to benefit from promotions and exemptions provided to R&D Centers within the scope of Law No. 5746.

Gaining R&D Center status, in addition to the fact that the company creates cost advantages in production activities, will increase cooperation with universities and other R&D institutions, this will clear the way for the company to focus its R&D efforts for the use of innovative and advanced technology and we believe that it will positively contribute to turnover and profitability by creating an important competitive advantage in the markets.

XI. RESEARCH AND DEVELOPMENTACTIVITIES

Within the scope of e-Transformation Information Management Systems in Health, e-Insurance Information Management Systems, Personal Health Record Information System and Hospital Information Management System (HIMS) projects running on Java-based Cloud Architecture R&D activities continue.

XII. SUBSIDIARIESANDBRANCHESOF THECOMPANY

Subsidiaries

Pidata Information Technologies Inc. has been founded as a wholly-owned subsidiary by Fonet Information Technologies Inc. in 2018 to develop projects, other than HIMS and to realize other information technology investment targets.

Activity Areas of PiData:

• To make R&D research,
• To research and develop value-added products which are needed in the market,
• To develop value added products other than HIMS (expert system, hardware components, etc.) in the Healthcare IT sector,
• To develop informatics solutions for the private sector,
• To develop ''e-Devlet'' projects.

Branches

We have four branches in Hacettepe Teknopolis, İstanbul, Şanlıurfa and Baku, Azerbaijan and a liaison office in Stockholm, Sweden.

Hacettepe Technopolis Branch:

Hacettepe Technopark 6th R&D Building, Block E, Floor 5, No:29 1596th Avenue, Üniversiteler District Çankaya/ANKARA

İstanbul Branch:

Emlak Kredi Blocks No: 33/4, Büyükdere Avenue Levent/İSTANBUL

Şanlıurfa Branch:

İpekyol Avenue No:12/1 ŞANLIURFA

Azerbaijan Branch:

Z. Ahmedbayov Avenue, No:2/46 Yasamal District Baku/AZERBAIJAN

Stockholm Liaison Office:

Klarabergsviadukten 70 D4, 111 64 Stockholm/ SWEDEN

XIII. OTHER ISSUES

After the end of the activity period, the particular importance issues that realized in the company and that may affect the rights of partners, creditors and other relevant persons and organizations are presented below for your information;

- Within the registered capital ceiling of TRY 2,500,000,000, an application was submitted to the Capital Markets Board on July 4, 2025, to increase our Company's issued capital from TRY 144,000,000 to TRY 936,000,000. Approval has been requested for the issuance certificate of shares with a nominal value of TRY 792,000,000 corresponding to the capital increase, of which TRY 392,125,929.24 is allocated from the positive differences arising from capital adjustment and TRY 399,874,070.76 from retained earnings. Additionally, a favorable opinion is sought for the amendment of Article 6, titled "Capital," of our Company's Articles of Association.

The company has announced the following developments to the public between 31st March 2025 and 30th June 2025 through the "Public Disclosure Platform" (KAP):

• - 08.04.2025: It has been decided by our Board of Directors, upon the recommendation of the Audit Committee and in accordance with the relevant provisions of the Turkish Commercial Code No. 6102 and the Capital Markets Law No. 6362, to appoint Eren Bağımsız Denetim ve Yeminli Mali Müşavirlik A.Ş. (Grant Thornton) as the independent auditor for the fiscal year 2025 to audit the financial statements, to perform other relevant activities under these regulations, and provided that it is authorized by the Public Oversight, Accounting and Auditing Standards Authority (KGK) to conduct independent assurance in the field of sustainability—to carry out the mandatory sustainability assurance audit of reports prepared in accordance with the Turkish Sustainability Reporting Standards (TSRS), with this appointment to be submitted for approval at the General Assembly.
• - 09.04.2025: The Ordinary General Assembly Meeting of our Company for 2024 was held on Wednesday, April 9, 2025, at 10:00, at Kızılırmak Mahallesi 1445. Sokak No: 2B/18 The Paragon Tower Çankaya / ANKARA.
• - 09.04.2025: At our Company's Ordinary General Assembly Meeting for the Year 2024, which was held on Wednesday, April 9, 2025, the decision of the Board of Directors to be deposited in the "Retained Earnings" account after the general legal reserve fund is set aside from the profit obtained as a result of the activities of the Board of Directors for the year 2024 was approved.
• - 09.04.2025: At the Ordinary General Assembly Meeting of our Company for the year 2024 held on Wednesday, April 9, 2025, in accordance with the principles determined pursuant to the Turkish Commercial Code No. 6102 and the Capital Markets Law No. 6362, it was resolved to audit the financial reports of our Company for the fiscal year 2025, to carry out other activities within the scope of the relevant regulations in these laws and to carry out other activities within the scope of the relevant regulations in these laws and to carry out the audit of the financial reports of our Company for the fiscal year 2025 and to carry out other activities within the scope of the relevant regulations in these laws, Eren Bağımsız Denetim ve Yeminli Mali Müşavirlik Anonim Şirketi (Grant Thornton) was approved to carry out other activities within the scope of the relevant regulations, including the mandatory sustainability assurance audit of the reports to be

prepared in accordance with the Turkish Sustainability Reporting Standards published by the KGK, provided that it is authorized by the Accounting and Auditing Standards Authority (KGK) to perform independent audit activities in the field of sustainability.

• - 09.04.2025: Mr. Abdülkerim GAZEN was elected as the Chairman of the Board of Directors and Mrs. Yasemin ŞAH was elected as the Vice Chairman of the Board of Directors by the Board of Directors of our Company.

• - 09.04.2025: At the meeting of our Board of Directors held on April 9, 2025; in accordance with the Corporate Governance Communiqué numbered II-17.1 of the Capital Markets Board and within the framework of the working principles of the Committees,

• Mr. Prof. Dr. Muhammet Ali AKCAYOL as Chairman of the Corporate Governance Committee and Mr. Dr. Emre SEZGİN and Mrs. Meltem KAVAK as its members,

• Mr. Prof. Dr. Sinan Altan KOCAMAN as Chairman of the Early Detection of Risk Committee and Mr. Dr. Emre SEZGİN as a member,

• Mr. Prof. Dr. Muhammet Ali AKCAYOL as the Chairman of the Audit Committee and Mr. Prof. Dr. Sinan Altan KOCAMAN as a member,

was elected unanimously.

• - 11.04.2025: Our Company's Ordinary General Assembly Meeting for 2024, held on 09.04.2025, was registered on 10 April 2025 and announced in the Trade Registry Gazette dated 11 April 2025 and numbered 11310.
• - 11.04.2025: At the Ordinary General Assembly Meeting of our Company for the year 2024 held on April 9, 2025, in accordance with the principles set forth in the Turkish Commercial Code No. 6102 and the Capital Markets Law No. 6362, it was resolved to audit the financial reports of our Company for the fiscal year 2025, to carry out other activities within the scope of the relevant regulations in these laws and to carry out other activities within the scope of the relevant regulations in these laws, and to carry out the Public Oversight and Auditing activities, It has been decided to select Eren Bağımsız Denetim ve Yeminli Mali Müşavirlik Anonim Şirketi (Grant Thornton) to carry out other activities within the scope of the relevant regulations, including the mandatory sustainability assurance audit of the reports to be prepared in accordance with the Turkish Sustainability Reporting Standards published by the KGK, provided that it is authorized by the Accounting and Auditing Standards Authority (KGK) to perform independent audit activities in the field of sustainability, and the decision was registered on April 10, 2025 and published in the Trade Registry Gazette dated April 11, 2025 and numbered 11310.
• - 14.04.2025: The Corporate Governance Information Form (Update) Shareholders has been announced to the public.
• - 17.04.2025: The contract that "23 months Health Information Management System (HIMS) Service Procurement" has been signed with Uşak Provincial Health Directorate with the amount of 35.449.302,00 Turkish Liras.
• - 28.04.2025: Our Company participated in a tender of "36 months Health Information Management System (HIMS) Service Procurement" that was made by Antalya Provincial Health Directorate on the date of 28.04.2025. There were 2 (two) companies participated in regarding tender that the best offer has been given by our company with the amount of 32.263.972,00 Turkish Liras.
• - 02.05.2025: Our Company participated in a tender of "36 months Health Information Management System (HIMS) Service Procurement" that was made by Eskişehir Provincial Health Directorate on the date of 02.05.2025. Regarding tender that the best offer has been given by our company with the amount of 57.059.235,00 Turkish Liras.
• - 12.05.2025: 2025 First Term Independent Audit Report has been announced to the public.
• - 12.05.2025: 2025 First Term Activity Report has been announced to the public.
• - 12.05.2025: 2025 First Term Responsibility Statement has been announced to the public.
• - 30.05.2025: Our company won the tender of ''36 months Health Information Management System (HIMS) Service Procurement'' that was made by Eskişehir Provincial Health Directorate with a tender price of 57.059.235,00 Turkish Liras. The legal objection process is expected and then the contract signing phase will be started.
• - 17.06.2025: The contract that "36 months Health Information Management System (HIMS) Service Procurement" has been signed with Eskişehir Provincial Health Directorate with the amount of 57.059.235,00 Turkish Liras.
• - 17.06.2025: At the meeting of our Board of Directors dated 17.06.2025,

I. To increase the issued capital of our Company from TRY 144,000,000 to TRY 936,000,000 (nine hundred and thirty-six million) within the registered capital ceiling of TRY 2,500,000,000 (two billion five hundred million), by increasing the issued capital of TRY 144,000,000 by 550% to TRY 936,000,000 (nine hundred and thirty-six million) entirely funded from internal resources,

II. TRY 392,125,929.24 of the increased capital of TRY 792,000,000 shall be covered from the Capital Adjustment Positive Differences, TRY 399,874,070.76 shall be covered from retained earnings and added to the capital, and that the shares to be issued shall be distributed to the shareholders free of charge,

III. Pursuant to Article 6 of the Articles of Association of the Company titled Capital and Type of Shares, the shares to be issued shall be issued as Class A Registered (TREFONT00028) shares, Class A Registered (TREFONT00028) shares, Class B Bearer (TREFONT00010) shares, Class B Bearer (TREFONT00010) shares,

IV. Within the scope of the aforementioned decision, to make the necessary applications to the relevant authorities, including the Capital Markets Board, Borsa

İstanbul A.Ş., Merkezi Kayıt Kuruluşu A.Ş., and to prepare all necessary documents for this purpose,

It was unanimously decided.

• - 23.06.2025: Company General Information Form was announced to the public.
• - 30.06.2025: Our Company participated in a tender of "36 months Health Information Management System (HIMS) and Intensive Care Information Management System (ICIS) Service Procurement" that was made by Bitlis Provincial Health Directorate on the date of 30.06.2025. Regarding tender that the best offer has been given by our company with the amount of 69.987.999,00 Turkish Liras.